FGC
PBYI icon

Financial Gravity Companies’s Puma Biotechnology PBYI Stock Holding History

Financial Gravity Companies’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$0 Buy
+1
New +$30 ﹤0.01% 1479
2018
Q1 		$0 Hold
1
– – ﹤0.01% 1576
2017
Q4 		$0 Buy
+1
New +$112 ﹤0.01% 1440

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Financial Gravity Companies's PBYI Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Puma Biotechnology (PBYI) in Q4 2018: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1479 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in PBYI as recently as Q1 2018.

Financial Gravity Companies first reported a position in PBYI in Q4 2017 and has held it in 3 quarters since. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

  • Financial Gravity Companies held 1 share of Puma Biotechnology worth $0 as of Q4 2018.
  • Puma Biotechnology was a new Financial Gravity Companies position in Q4 2018.
  • Puma Biotechnology made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1479 holding.
  • Financial Gravity Companies first reported a position in Puma Biotechnology in Q4 2017 and has held it in 3 quarters since.
  • 141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.